Year: 2026
Type: article
Abstract: As the global population ages, innovative strategies for cancer management in older adults are urgently needed. Liquid biopsy, a non-invasive tool, offers great promise for this demographic by enabling early detection, real-time monitoring, and therapeutic target identification. This review highlights the clinical utility, feasibility, and safety of liquid biopsies in geriatric oncology, emphasizing their potential integration into routine care to improve treatment outcomes and quality of life for older patients.
Source: npj Precision Oncology
Institutions: University Hospital Cologne, Pennsylvania State University, University of Dundee, NHS Tayside, Ninewells Hospital, University of Basel, Lyon 1 Université, Inserm, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Hospices Civils de Lyon, Hôpital Lyon Sud, Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition, University Hospitals of the Ruhr-University of Bochum, Universitätsklinik Marien Hospital Herne, University of Rochester Medicine, City Of Hope National Medical Center, City of Hope, Universitair Ziekenhuis Leuven, Royal Marsden NHS Foundation Trust
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,090
OpenAlex ID: W7128083946